Our confirmed keynote speakers:
Alexander van Oudenaarden
Prof. dr. ir. Alexander van Oudenaarden
Hubrecht Institute-KNAW, University Medical Center Utrecht & Utrecht University
Prof. dr. ir. Alexander van Oudenaarden is director and group leader at the Hubrecht Institute (KNAW) and professor of quantitative biology of gene regulation at the Faculty of Science and the Faculty of Medicine at Utrecht University. His research group works with advanced (light) microscopy and sequencing technologies in order to study individual cells. Van Oudenaarden studied materials science and physics at Delft, where he also obtained his PhD in solid state physics. As a postdoc he worked at Stanford University collaborating with Steven Boxer and Julie Theriot. He was professor of physics and biology at the Massachusetts Institute of Technology (MIT). In 2012 he moved to the Hubrecht Institute after 15 years in the USA. His group combines techniques – in part developed by themselves – from developmental biology, molecular biology, physics, mathematics and computer science. He was awarded the 2011 and 2016 ERC Advanced Investigator grant and in 2017 van Oudenaarden won the Spinoza Award.
Dr Martin Kircher
Junior Group Leader 'Computational Genome Biology’
Berlin Institute of Health
Dr. Martin Kircher joined BIH in March 2017 as a new Junior Research Group (JRG) Leader in the field of Bioinformatics. He describes the work of his "Computational Genome Biology" group and experience in a brief portrait.
The research of his group focuses on computational approaches of identifying functionally relevant genetic changes in disease and adaptation as well as developing more sensitive methods in diagnostics (especially exome, genome and cell-free DNA sequencing). Generally, our research spans the fields of sequence analysis, data mining, machine learning and functional genomics.
Based on a broad interest in genetics, epigenetics, and human adaptation, the group develops computational solutions to overcome technical and experimental obstacles in high-throughput sequencing-based protocols. The main focus area are computational approaches for identifying functionally relevant genetic.
Assistant Professor of Pharmacology & Cancer Biology
Our lab is part of the Department of Pharmacology and Cancer Biology at Duke University. We are also members of the Duke Cancer Institute and the Duke Molecular Physiology Institute. We have a longstanding interest in understanding the structure and function of metabolic networks in health and pathology. We are a diverse group with equally diverse skills in analytical chemistry, genetics, computational biology, bioinformatics, and mathematics, and biochemistry allowing us to solve complex biological problems with an integrative and collaborative approach.
Our research focuses on an integrated understanding of metabolism in health and disease. We direct these efforts toward understanding the role of altered metabolism in cancer, emphasizing its targetable liabilities and downstream effects on cellular physiology, notably its influence on the chromatin state. At the core of this effort lies the utilization of computational modeling and high throughput technologies such as mass spectrometry-based metabolomics. We define our systems biology approach through combining these tools with an integration of genetics, biochemistry, and cell biology. Investing such effort we believe has the potential to fundamentally alter our understanding of disease biology and lead to innovative therapies.
Chiara Dalla Man
Chiara Dalla Man
Associate professor in Bioengineering
University of Padova, Department of Information Engineering
Chiara Dalla Man was born in Venice in the 1977. She received the Master Degree (cum laude) in Electrical Engineering in 2000 and the PhD in Bioengineering in 2005 both from the University of Padova. She is currently associate professor in Bioengineering at the Department of Information Engineering of the University of Padova. Her research is in the field of mathematical modeling of endocrine and metabolic systems and diabetes treatment, in collaboration with several Italian and foreign researchers. She is coauthor of more than 80 scientific articles, published in prestigious journals of the field, and member of the editorial board of Journal of Diabetes Science and Technology and Frontiers in Systems Biology.
BioSB 2018Registration website for BioSB 2018
BioSB 2018BioSB 20180.00
Conference Centre De WereltConference Centre De WereltWesthofflaan 2